COL17A1 modulation

1. A bioelectric stimulator programmed to produce at least one bioelectric signal that upregulates expression of COL17A1 in living target tissue, wherein the at least one bioelectric signal is a biphasic, square-wave pulse with a 50% duty cycle having a frequency of

25 Hz (+/−20 Hz) or

5,000 Hz

at 10 mV to 100 mV.

2. The bioelectric stimulator of claim 1 , wherein the at least one bioelectric signal has a frequency of 25 Hz (+/−10 Hz).

3. The bioelectric stimulator of claim 2 , wherein the bioelectric signal is 25 Hz at 10 mV.

4. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a further bioelectric signal of 3 V/cm, 10 Hz, 2 μA (0.000002 amps), and pulse duration of 0.2 ms.

5. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a further bioelectric signal of 20 V/cm, 100 Hz, 0.25 μA (2.5e-7 amps), and pulse duration of 40 pulses/s, width of 100 μs.

6. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a further bioelectric signal of 50 Hz and 100 Hz for one (1) minute.

7. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a further bioelectric signal of 50 Hz alternating electrical field and electric current of 1 mA for 15 minutes for minutes.

8. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce a further bioelectric signal applied to the target tissue of 3 mV with electric frequency of 22 Hz, and current of 1 mA for 15 minutes and 3 mA for 15 minutes.

9. A method of using the bioelectric stimulator of claim 1 to stimulate tissue of a subject to upregulate expression of COL17A1, the method comprising: connecting the bioelectric stimulator to the target tissue of the subject, and

actuating the bioelectric stimulator to produce the programmed bioelectric signal(s) so as to stimulate the tissue and upregulate the expression of COL17A1 and thus produce collagen XVII.

10. The method according to claim 9 , further comprising:

delivering to the tissue a skin regeneration composition mix comprising adipose tissue-derived stem cells, exosomes, micro RNAs, hydrogel skin matrix, elastin, oxygenated nanoparticles, platelet rich fibrin (“PRF”), amniotic fluid, and growth factors.

11. The method according to claim 9 , further comprising:

delivering to the tissue a compound selected from the group consisting of platelet rich fibrin (“PRF”), amniotic fluid, adipose tissue-derived stem cells, a hydrogel and stem cell matrix-based skin cream, hydrogel skin matrix, oxygenated nanoparticles, and a combination of any thereof.

12. The method according to claim 9 , further comprising:

electrical stimulation of the tissue with conductive electro-massaging gloves,

conducting electro acupuncture with the tissue, and/or

delivering to the tissue LED-pulsed light therapy.

13. The method according to claim 9 , further comprising:

applying to the tissue amniotic fluid membrane dressings.

14. A bioelectric stimulator, wherein the bioelectric stimulator is programmed to produce at least one bioelectric signal that downregulates expression of COL17A1 in living target tissue, wherein the bioelectric signal is a biphasic, square-wave pulse with a 50% duty cycle having a frequency of:

50 Hz at 60 mV to 100 mV,

75 Hz (+/−10-20 Hz) at 100 mV, or

250,000 Hz at 1 V.

15. The bioelectric stimulator of claim 14 , wherein the bioelectric signal has a frequency of 50 Hz.

16. The bioelectric stimulator of claim 15 , wherein the bioelectric signal is 100 mV as may be measured in the living target tissue.

17. The bioelectric stimulator of claim 14 , wherein the bioelectric signal has a frequency of 75 Hz.

18. The bioelectric stimulator of claim 14 , wherein the bioelectric signal has a frequency of 250,000 Hz.

19. A method of upregulating expression of COL17A1 in living target tissue to stimulate the living target tissue to produce collagen XVII, the method comprising:

applying at least one bioelectric signal that upregulates expression of COL17A1 in the living target tissue,

wherein the at least one bioelectric signal to upregulate expression of COL17A1 is a biphasic, square-wave pulse with a 50% duty cycle having a frequency of

25 Hz (+/−20 Hz) or

5,000 Hz

at 10 mV to 100 mV as may be measured in the living target tissue,

so as to stimulate the living target tissue to upregulate expression of COL17A1 and thus produce collagen XVII in the living target tissue.

20. The method according to claim 19 , wherein the bioelectric signal is a 10 mV, 25 Hz, biphasic, square-wave pulse with a 50% duty cycle.